Related Experiment Video

Updated: Aug 8, 2026

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 11, 2013

Cellular responses to antimetabolite anticancer agents: cytostasis versus cytotoxicity

J A Houghton1, P J Houghton

  • 1Department of Molecular Pharmacology St. Jude Children's Research Hospital, Memphis, TN 38105-2794, USA.

Progress in Cell Cycle Research
|January 1, 1996
PubMed

Insights

Thymineless death, a cancer cell response to antimetabolites, triggers apoptosis. Emerging data suggests p53 plays a key role in deciding between cell cycle arrest (cytostasis) or cell death (apoptosis).

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Death Mechanisms

Background:

  • Thymineless death is a critical cytotoxic response to antimetabolite chemotherapy for carcinomas and hematopoeitic malignancies.
  • Lack of deoxythymidine (dThd) leads to cell death, characterized by DNA nucleosomal ladders, classifying it as apoptosis.
  • While drug resistance is well-studied, downstream events determining cancer cell fate after dTTP depletion remain less understood.

Purpose of the Study:

  • To review emerging data on the role of p53 in cellular responses to deoxythymidine (dThd) deprivation.
  • To elucidate the mechanisms determining whether cancer cells undergo cytostasis or apoptosis when dThd is unavailable.

Main Methods:

  • Review of existing scientific literature and emerging research data.
  • Analysis of studies investigating the downstream effects of dTTP depletion in cancer cells.
  • Examination of the involvement of the p53 tumor suppressor protein in cell fate decisions.

Main Results:

  • Emerging data indicates that p53 influences the cellular outcome following dThd deprivation.
  • The p53 protein appears to be a critical determinant in switching the cellular response from cytostasis to apoptosis.
  • Understanding p53's role could reveal new therapeutic strategies for overcoming drug resistance.

Conclusions:

  • p53 is a key regulator in the thymineless death pathway, dictating cancer cell fate.
  • The p53 status of a tumor may predict its response to antimetabolite therapies.
  • Further research into p53-mediated downstream events is crucial for optimizing cancer treatment.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity07:58

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Published on: May 12, 2020

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...